Business Context and Reporting Period
This Form 8-K is a current report filed by Leap Therapeutics, Inc. (not Cypherpunk Technologies Inc.) on February 5, 2019. The registrant is a Delaware corporation and an emerging growth company. The report discloses the closing of a previously announced public offering of common stock and warrants to purchase common stock.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a notification of a capital event rather than a financial performance report.
Material Changes
- Capital Raise: The company closed a public offering of common stock and warrants on February 5, 2019.
- Securities Issued: The offering included both common stock and warrants to purchase common stock.
Guidance, Outlook, and Risks
The filing incorporates by reference a press release (Exhibit 99.1) regarding the offering but does not contain specific management commentary, forward-looking guidance, risk factors, or contingencies within the text of the 8-K itself. The company is identified as an emerging growth company, which may impact its reporting obligations.
Investor Verification Checklist
- Verify the total gross proceeds and net proceeds from the offering by reviewing the attached press release (Exhibit 99.1).
- Confirm the number of shares and warrants issued and the exercise price of the warrants.
- Review the underwriting agreement details to understand any lock-up periods or over-allotment options.
- Check subsequent filings (e.g., 10-K or 10-Q) for the impact of this capital raise on the company's cash position and burn rate.